| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Disease; Hyperkinesis; Mental Disorders; Problem Behavior | Phase 1/Phase 2 | ClinicalTrials |
| Depression; Depressive Disorder | Phase 2 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity; Hyperkinesis | Phase 2 | ClinicalTrials |
CONTENTS